Access to Treatment in the Private-sector Workplace: The Provision of Antiretroviral Therapy by Three Companies in South Africa
Companies cannot ignore HIV; it is a business issue demanding a response now and influencing longer term strategic planning. HIV infection among employees poses a significant threat to operational stability and future profitability. This study outlines how three major companies operating in South Africa have recognized both the challenges HIV poses and their moral duty of care, and have implemented programs to treat and care for employees and their families.
access to antiretroviral access to treatment adherence AIDS epidemic AIDS programme AIDS-related Anglo American ANGLO AMERICAN plc antiretroviral drugs antiretroviral therapy programme antiretroviral treatment Aurum best practice BHP Billiton Carletonville CD4 count Coalition on HIV/AIDS Code of Practice company’s condoms conﬁdential voluntary counselling corporate costs counselling and testing countries disease-management economic employees living ensure epidemic’s Eskom estimated example families ﬁnancial ﬁrst Futures Group International Geneva GIPA Global Business Coalition Global Fund health services health-care services HIV and AIDS HIV prevalence HIV status HIV-positive employees hostels ILO Code implemented Initiative International Labour Organization involved issues Lifeworks living with HIV medical aid companies migrant nutrition operations opportunistic infections partnership patient peer educators policies and programmes prevention primary health-care providing antiretroviral therapy rates reﬂect response to HIV Roos sexually transmitted infections signiﬁcant South Africa speciﬁc staff stigma and discrimination survey three companies workforce workplace policies